Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Adalimumab for Inflammatory Osteoarthritis

This study has been completed.
Information provided by (Responsible Party):
Walter Maksymowych, University of Alberta Identifier:
First received: May 26, 2008
Last updated: June 12, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):